Trials / Sponsors / Noah Hahn, M.D.
Noah Hahn, M.D.
Academic / Other · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Urothelial Carcinoma, Bladder Cancer | Phase 1 / Phase 2 | 2017-11-21 |
| Completed | Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer Bladder Cancer, Urothelial Carcinoma | Phase 2 | 2013-04-01 |
| Terminated | Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression Bladder Cancer | Phase 2 | 2013-03-01 |
| Terminated | Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer Prostate Cancer | Phase 2 | 2009-03-01 |
| Terminated | Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC Transitional Cell Carcinoma of the Bladder | Phase 2 | 2009-03-01 |